<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Role of lung biopsy in the diagnosis of interstitial lung disease
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Role of lung biopsy in the diagnosis of interstitial lung disease
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Role of lung biopsy in the diagnosis of interstitial lung disease
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Talmadge E King, Jr, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Rishi Raj, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Kevin R Flaherty, MD, MS
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Andrew Nicholson, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Henri G Colt, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Paul Dieffenbach, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Nov 06, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diffuse parenchymal lung diseases, often collectively referred to as the interstitial lung diseases (ILDs), are a heterogeneous group of disorders that are classified together because of similar clinical, radiographic, physiologic, or pathologic manifestations  (
         <a class="graphic graphic_algorithm graphicRef77345" href="/z/d/graphic/77345.html" rel="external">
          algorithm 1
         </a>
         ). The results of clinical assessment, laboratory tests, imaging, and pulmonary function tests guide the decisions about whether to pursue transbronchoscopic, thoracoscopic, or surgical lung biopsy, as outlined in the algorithm  (
         <a class="graphic graphic_algorithm graphicRef69044" href="/z/d/graphic/69044.html" rel="external">
          algorithm 2
         </a>
         ).
        </p>
        <p>
         The indications and methods for obtaining lung biopsies to evaluate ILD will be reviewed here. The clinical evaluation, diagnostic testing, role of bronchoalveolar lavage, and histopathologic patterns commonly encountered in adults with suspected ILD are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/4310.html" rel="external">
          "Approach to the adult with interstitial lung disease: Clinical evaluation"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4358.html" rel="external">
          "Approach to the adult with interstitial lung disease: Diagnostic testing"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4303.html" rel="external">
          "Basic principles and technique of bronchoalveolar lavage"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4308.html" rel="external">
          "Role of bronchoalveolar lavage in diagnosis of interstitial lung disease"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          OVERVIEW
         </span>
         <span class="headingEndMark">
          —
         </span>
         When the results of clinical evaluation, laboratory testing, imaging studies including high-resolution computed tomography (HRCT), and pulmonary function testing do not allow the clinician to make a confident diagnosis of a given type or stage of ILD, lung biopsy with careful examination of lung tissue is often necessary  (
         <a class="graphic graphic_algorithm graphicRef69044" href="/z/d/graphic/69044.html" rel="external">
          algorithm 2
         </a>
         ) [
         <a href="#rid1">
          1,2
         </a>
         ]. The evaluation of ILD leading up to lung biopsy is described separately. (See
         <a class="medical medical_review" href="/z/d/html/4310.html" rel="external">
          "Approach to the adult with interstitial lung disease: Clinical evaluation"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4358.html" rel="external">
          "Approach to the adult with interstitial lung disease: Diagnostic testing"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4256910517">
         <span class="h2">
          Indications
         </span>
         <span class="headingEndMark">
          —
         </span>
         Lung biopsy is generally helpful in the evaluation of patients with ILD in the following situations:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         To provide a specific diagnosis. This is especially desirable in a patient with clinical features such as age &lt;50 years, fever, weight loss, hemoptysis, or signs of vasculitis; a progressive course; atypical or rapidly changing HRCT findings; unexplained extrapulmonary manifestations; or pulmonary vascular disease of unclear origin.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         To exclude neoplastic and infectious processes that can mimic chronic, progressive ILD.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         To identify a more treatable process than originally suspected (eg, hypersensitivity pneumonitis versus idiopathic pulmonary fibrosis).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         To predict the likelihood of response to therapy before proceeding with therapies that may have serious side effects (eg, cellular nonspecific interstitial pneumonia or organizing pneumonia versus idiopathic pulmonary fibrosis) [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Rarely, to diagnose ILD in a patient with hypoxemia, pulmonary function tests strongly suggestive of ILD, a negative evaluation for pulmonary vascular disease, and a normal HRCT.
        </p>
        <p>
        </p>
        <p>
         Lung tissue can be obtained via transbronchial biopsy (TBLB), transbronchial cryobiopsy (cryo-TBB), thoracotomy, or video-assisted thoracoscopic surgery (VATS). The specific settings in which one procedure is preferred over the others are discussed below. (See
         <a class="local">
          'Transbronchial lung biopsy'
         </a>
         below and
         <a class="local">
          'When is lung biopsy unlikely to be helpful?'
         </a>
         below.)
        </p>
        <p>
         Patient preference must also be considered. Patients with minimal symptoms, signs, physiologic impairment, and radiographic abnormality may prefer close observation over several months with interval repetition of pulmonary function tests and HRCT, rather than proceeding immediately to lung biopsy. Other patients prefer to undergo a lung biopsy sooner to obtain a definitive diagnosis and clarify their prognosis, rather than watchful waiting.
        </p>
        <p class="headingAnchor" id="H3590873593">
         <span class="h2">
          Relative contraindications
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with relative contraindications to lung biopsy should be evaluated on a case-by-case basis to be sure that the procedure is likely to reveal a treatable diagnosis at an acceptable level of risk and that less invasive methods will not yield a diagnosis. As examples, patients with an underlying solid or hematologic malignancy may have ILD that is not treatable (eg, fibrotic pneumonitis due to irradiation) and immunosuppressed patients may have a diagnosis that can be determined by less invasive methods (eg, bronchoalveolar lavage).
        </p>
        <p>
         Relative contraindications to lung biopsy include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Radiographic evidence of diffuse end-stage disease, eg, "honeycombing," without areas of milder disease activity, as biopsy of end-stage fibrosis is unlikely to reveal an etiology.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Extensive pleural disease or emphysema that increase the risk of biopsy.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Severe pulmonary dysfunction manifest by a diffusing capacity (DLCO) less than 35 percent predicted, severe hypoxemia needing supplemental oxygen, or respiratory failure requiring mechanical ventilation.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Serious cardiovascular disease, advanced age [
         <a href="#rid4">
          4
         </a>
         ], bleeding disorder, or other major risks for surgery or general anesthesia.
        </p>
        <p>
        </p>
        <p>
         Transbronchial cryobiopsy or transbronchial lung biopsy may be performed in selected patients who are not candidates for surgical lung biopsy due to one or more of these factors, but in whom a diagnosis may substantially alter therapy or prognosis.
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h1">
          TRANSBRONCHIAL LUNG BIOPSY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Transbronchial lung biopsies (TBLB) are obtained during flexible bronchoscopy, using biopsy forceps that are passed through the channel of the bronchoscope. The equipment and technique of flexible bronchoscopy with TBLB are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/4398.html" rel="external">
          "Flexible bronchoscopy in adults: Overview"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/106085.html" rel="external">
          "Flexible bronchoscopy in adults: Associated diagnostic and therapeutic procedures", section on 'Transbronchial biopsy'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3208512674">
         <span class="h2">
          When is TBLB most helpful?
         </span>
         <span class="headingEndMark">
          —
         </span>
         TBLB is often the biopsy procedure of choice when the suspected ILD is likely to have a centrilobular location  (
         <a class="graphic graphic_diagnosticimage graphicRef75540" href="/z/d/graphic/75540.html" rel="external">
          image 1
         </a>
         ) and when a diagnosis can be made from small samples of lung tissue [
         <a href="#rid5">
          5
         </a>
         ]. Examples of centrilobular diseases include sarcoidosis, hypersensitivity pneumonitis, lymphangitic carcinomatosis, eosinophilic pneumonia, and alveolar proteinosis [
         <a href="#rid5">
          5-8
         </a>
         ]. Infection can often be diagnosed on a small biopsy sample. (See
         <a class="medical medical_review" href="/z/d/html/6988.html" rel="external">
          "High resolution computed tomography of the lungs", section on 'Centrilobular nodules'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4310.html" rel="external">
          "Approach to the adult with interstitial lung disease: Clinical evaluation"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4358.html" rel="external">
          "Approach to the adult with interstitial lung disease: Diagnostic testing"
         </a>
         .)
        </p>
        <p>
         Sarcoidosis tends to have a centrilobular distribution and a characteristic histopathologic finding of diffuse noncaseating granulomas, giving TBLB a high likelihood of diagnostic success in suspected sarcoidosis. The benefit of TBLB was demonstrated in a series of 150 patients with suspected sarcoidosis: 88 patients had granulomas on TBLB, an additional 10 had granulomas on endobronchial biopsy, and 9 had findings diagnostic of another disease, bringing the overall rate of diagnosis to 71 percent [
         <a href="#rid9">
          9
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4353.html" rel="external">
          "Clinical manifestations and diagnosis of sarcoidosis", section on 'Endobronchial and transbronchial biopsy'
         </a>
         .)
        </p>
        <p>
         A positive TBLB with typical histopathologic findings can also be diagnostic in a small subset of patients with subacute hypersensitivity pneumonitis, cryptogenic organizing pneumonia, or pulmonary alveolar proteinosis in the context of an appropriate clinical presentation and typical HRCT findings [
         <a href="#rid5">
          5,10-12
         </a>
         ]. These patients should be followed closely and further diagnostic procedures (eg, a surgical lung biopsy) should be considered if their temporal course or response to therapy is inconsistent with the working diagnosis [
         <a href="#rid10">
          10
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4313.html" rel="external">
          "Hypersensitivity pneumonitis (extrinsic allergic alveolitis): Clinical manifestations and diagnosis", section on 'Surgical lung biopsy'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4373.html" rel="external">
          "Causes, clinical manifestations, and diagnosis of pulmonary alveolar proteinosis in adults", section on 'Diagnostic evaluation'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4332.html" rel="external">
          "Cryptogenic organizing pneumonia", section on 'Invasive testing to rule out alternative diagnoses'
         </a>
         .)
        </p>
        <p>
         TBLB is less likely to be helpful when the pattern on high-resolution computed tomography (HRCT) is indeterminant or suggests an idiopathic interstitial pneumonia  (
         <a class="graphic graphic_algorithm graphicRef69044" href="/z/d/graphic/69044.html" rel="external">
          algorithm 2
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/4302.html" rel="external">
          "Idiopathic interstitial pneumonias: Classification and pathology"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3887352282">
         <span class="h2">
          What are the diagnostic limitations?
         </span>
         <span class="headingEndMark">
          —
         </span>
         TBLB are a few millimeters in size and are subject to crush artifact. They may miss the correct diagnosis when the disease is patchy or when visualization of whole pulmonary acini is needed to fully evaluate disease distribution. Examples include granulomatosis with polyangiitis and other vasculitides that typically require examination of arteries and arterioles that are larger than those obtained by TBLB and the idiopathic interstitial pneumonias, particularly idiopathic pulmonary fibrosis.
        </p>
        <p class="headingAnchor" id="H1840496715">
         <span class="h3">
          Idiopathic pulmonary fibrosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         TBLB cannot be used to make a conclusive diagnosis of idiopathic pulmonary fibrosis (IPF), based on the absence of prospective studies utilizing an acceptable gold standard that demonstrates the usefulness of TBLB in the diagnosis of usual interstitial pneumonia (UIP), the histologic pattern associated with IPF [
         <a href="#rid13">
          13-16
         </a>
         ]. While transbronchial biopsy is rarely sufficient to make a pathological diagnosis of UIP, a properly performed and interpreted transbronchial biopsy that is negative for an alternative diagnosis does increase the post-test probability of idiopathic pulmonary fibrosis in patients who already have a high pre-test probability of IPF [
         <a href="#rid14">
          14
         </a>
         ].
        </p>
        <p>
         The reason that TBLB is unsuccessful in the diagnosis of IPF is that the histopathologic diagnosis of UIP depends on the low power visualization of gross architectural features such as the repetitive combination of patchy fibrosis, fibroblastic foci, and microscopic honeycombing with intervening normal lung parenchyma, changes that cannot be appreciated on a transbronchial biopsy [
         <a href="#rid17">
          17
         </a>
         ]. Additionally, areas of more diffuse fibrotic nonspecific interstitial pneumonia (NSIP)-like fibrosis, that are commonly seen in UIP can easily be distinguished on a surgical lung biopsy, but not on a transbronchial biopsy [
         <a href="#rid17">
          17
         </a>
         ].
        </p>
        <p>
         Varying combinations of histopathologic findings suggestive of UIP, including fibroblastic foci, patchy interstitial fibrosis, and honeycombing, have been demonstrated in a minority of transbronchial biopsy studies. In a retrospective series, features of UIP were present in 12/30 TBLB specimens from patients who had definite UIP for a sensitivity of 30 percent [
         <a href="#rid14">
          14
         </a>
         ].
        </p>
        <p>
         Importantly, individual features of UIP such as honeycombing or fibroblastic foci in themselves are not specific for UIP and can be found in other disorders, such as drug reactions, chronic hypersensitivity pneumonitis, rheumatic diseases, and asbestosis [
         <a href="#rid17">
          17
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4048615645">
         <span class="h3">
          Non-IPF idiopathic interstitial pneumonias
         </span>
         <span class="headingEndMark">
          —
         </span>
         In the idiopathic interstitial pneumonias (IIPs)  (
         <a class="graphic graphic_table graphicRef95445" href="/z/d/graphic/95445.html" rel="external">
          table 1
         </a>
         ), histopathologic pattern and distribution are key to the diagnosis, and studies have found a low diagnostic yield in patients with IIP undergoing transbronchial biopsy [
         <a href="#rid5">
          5,6
         </a>
         ]. We suggest not pursuing TBLB in patients suspected of having an IIP, particularly IPF (see
         <a class="local">
          'Idiopathic pulmonary fibrosis'
         </a>
         above). However, a potential exception is suspected cryptogenic organizing pneumonia, in which a TBLB with typical histopathologic findings might be sufficient in the appropriate clinical and radiologic context [
         <a href="#rid12">
          12
         </a>
         ]. (See
         <a class="local">
          'When is TBLB most helpful?'
         </a>
         above.)
        </p>
        <p>
         The histopathologic features of the various IIPs are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/4302.html" rel="external">
          "Idiopathic interstitial pneumonias: Classification and pathology"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4657761">
         <span class="h2">
          Safety
         </span>
         <span class="headingEndMark">
          —
         </span>
         TBLB is a safe, minimally invasive procedure with an estimated mortality of &lt;0.05 percent [
         <a href="#rid5">
          5,9,18
         </a>
         ]. Pneumothorax is estimated to occur in 0.7 to 2 percent, although rates up to 10 percent have been reported; less than half require tube thoracostomy drainage [
         <a href="#rid1">
          1,5,14,18,19
         </a>
         ]. Bleeding (&gt;50 mL) is reported in 1 to 4 percent [
         <a href="#rid5">
          5
         </a>
         ]. Additional information about the risks of TBLB and bronchoscopy in general and precautions to minimize procedure-related bleeding are provided separately. (See
         <a class="medical medical_review" href="/z/d/html/4398.html" rel="external">
          "Flexible bronchoscopy in adults: Overview"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/105799.html" rel="external">
          "Flexible bronchoscopy in adults: Preparation, procedural technique, and complications", section on 'Complications'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H20485052">
         <span class="h2">
          Specimen collection and diagnostic yield
         </span>
         <span class="headingEndMark">
          —
         </span>
         In patients with ILD, the location selected for TBLB is generally an area that appears involved on HRCT. Of note, it is general practice NOT to perform bilateral transbronchial biopsies during a single bronchoscopy because of the risk of bilateral iatrogenic pneumothorax. Specimens that float are no more likely to be diagnostic than those that do not float [
         <a href="#rid20">
          20
         </a>
         ]. The role of fluoroscopic guidance during TBLB is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/106085.html" rel="external">
          "Flexible bronchoscopy in adults: Associated diagnostic and therapeutic procedures", section on 'Transbronchial biopsy'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cupped versus toothed forceps
         </strong>
         – The data are conflicting on whether diagnostic yields are greater with cupped or toothed forceps. Larger TBLB specimens are more likely to yield diagnostic information.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         In a trial that randomly assigned 150 patients undergoing TBLB for suspected sarcoidosis to use of cup forceps or toothed (alligator) forceps, the rate of positive biopsies was not different between the groups, although complications were slightly lower with toothed forceps [
         <a href="#rid9">
          9
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         A separate trial randomly assigned 44 patients to cupped or toothed forceps and four biopsies were obtained from each patient [
         <a href="#rid21">
          21
         </a>
         ]. While the size of the biopsies was slightly greater with toothed forceps, the rate of diagnosis was not different between the groups. Pneumothorax and bleeding occurred slightly more often with cupped forceps.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         In an earlier series that examined 170 TBLB specimens, toothed forceps typically provided larger specimens than cupped forceps and were more likely to yield diagnostic information [
         <a href="#rid20">
          20
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Number of TBLB specimens
         </strong>
         – The optimal number of TBLB specimens reflects a balance between the expected diagnostic yield and the patient's tolerance of the procedure. Usually, four to six TBLB specimens are obtained [
         <a href="#rid5">
          5,19,20,22-24
         </a>
         ]. The effect of the number of transbronchial biopsies on diagnostic yield has been examined in case series, although the data are influenced by the underlying ILD. Among 244 patients with diffuse ILD, the diagnostic yield was 50 percent, based on five to six biopsies [
         <a href="#rid19">
          19
         </a>
         ]. In a series of 24 patients with interstitial lung disease, 118 biopsies were obtained (average five per patient) of which 78 percent were of adequate quality and gave an overall diagnostic yield of 74 percent [
         <a href="#rid25">
          25
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4658609">
         <span class="h2">
          Ancillary tests
         </span>
         <span class="headingEndMark">
          —
         </span>
         When performing flexible bronchoscopy in patients with interstitial lung disease, endobronchial biopsy and bronchoalveolar lavage (BAL) are often performed during the same procedure as TBLB although the data in support of this practice are limited. Transbronchial needle aspirate of enlarged mediastinal or hilar lymph nodes using an ultrasound guided probe can also be performed during the same procedure if the appropriate equipment is available.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Endobronchial biopsy
         </strong>
         – Endobronchial mucosal biopsies can be helpful in patients suspected of having sarcoidosis or chronic beryllium disease. Four to six endobronchial biopsies are usually obtained, preferably from a site where the mucosa appears erythematous or from the first and secondary carinas if the mucosa appears normal [
         <a href="#rid5">
          5
         </a>
         ]. In sarcoidosis, endobronchial mucosal biopsies are frequently positive and may increase the diagnostic yield, compared with transbronchial biopsies alone [
         <a href="#rid9">
          9,26
         </a>
         ]. In a series of 37 patients with sarcoidosis, endobronchial biopsies had a diagnostic yield of 24 percent and increased the yield over transbronchial biopsy alone by 8 percent. (See
         <a class="medical medical_review" href="/z/d/html/4367.html" rel="external">
          "Chronic beryllium disease (berylliosis)", section on 'Endobronchial and transbronchial biopsy'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4353.html" rel="external">
          "Clinical manifestations and diagnosis of sarcoidosis", section on 'Endobronchial and transbronchial biopsy'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Bronchoalveolar lavage
         </strong>
         – Results of BAL are generally not diagnostic in ILD, but frequently provide supportive evidence for or against a diagnosis. We typically perform BAL after obtaining the TBLB specimens and avoid performing BAL in the same subsegments as the TBLB. The role of BAL in the evaluation of ILD and the analysis of lavage fluid are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/4398.html" rel="external">
          "Flexible bronchoscopy in adults: Overview"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4308.html" rel="external">
          "Role of bronchoalveolar lavage in diagnosis of interstitial lung disease"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Ultrasound-guided transbronchial needle aspiration of mediastinal or hilar lymph nodes
         </strong>
         – Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) requires a special bronchoscope and is performed under general anesthesia, typically with a laryngeal mask airway in place. It is performed to evaluate enlarged hilar and mediastinal lymph nodes. The bronchoscope for EBUS is different from the standard bronchoscope used for TBLB, but general anesthesia and the laryngeal mask airway make it relatively easy to change bronchoscopes and perform both EBUS-TBNA and TBLB during a single procedure [
         <a href="#rid27">
          27
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4386.html" rel="external">
          "Endobronchial ultrasound: Indications, contraindications, and complications"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         EBUS-TBNA has a yield of 90 to 96 percent for the diagnosis of sarcoidosis in the presence of hilar or mediastinal adenopathy. The technique of EBUS-TBNA is described separately. (See
         <a class="medical medical_review" href="/z/d/html/4383.html" rel="external">
          "Bronchoscopy: Transbronchial needle aspiration", section on 'Technical considerations'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4385.html" rel="external">
          "Endobronchial ultrasound: Technical aspects"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3272807146">
         <span class="h1">
          DECISION TO PERFORM MORE INVASIVE BIOPSIES
         </span>
         <span class="headingEndMark">
          —
         </span>
         Surgical lung biopsy (SLB) and transbronchial cryobiopsy (cryo-TBB) allow for larger specimens and higher diagnostic yield in patients with unclassifiable ILD based on clinical, laboratory, and radiographic features. However, these procedures carry increased risk of morbidity and adverse events and are not appropriate for all patients.
        </p>
        <p class="headingAnchor" id="H211389428">
         <span class="h2">
          When is lung biopsy unlikely to be helpful?
         </span>
         <span class="headingEndMark">
          —
         </span>
         Not all patients with ILD need a lung biopsy because the combination of history, physical examination, radiologic imaging, physiologic testing, and other ancillary testing is sufficiently diagnostic, especially when combined with multidisciplinary evaluation. A lung biopsy in these patients adds little diagnostic and prognostic information, does not change therapy, and should be avoided. Two specific subpopulations in which surgical lung biopsy is generally not necessary are patients with a known systemic rheumatic disease and patients presenting with previously undiagnosed ILD and respiratory failure.
        </p>
        <p class="headingAnchor" id="H732735771">
         <span class="h3">
          Interstitial lung disease associated with systemic rheumatic disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         Lung biopsy should generally be avoided in patients with ILD associated with a systemic rheumatic disease. It is uncommon for histopathologic information to provide information that cannot be obtained by noninvasive means, and the treatment for ILD associated with systemic rheumatic disease is generally dictated by factors such as extent of disease, physiologic impairment, and rate of progression rather than the underlying histopathology [
         <a href="#rid28">
          28-33
         </a>
         ]. In patients with RA undergoing lung biopsy, the proportions of patients with UIP, NSIP, and bronchiolar disease are approximately 30 percent each [
         <a href="#rid32">
          32,34-36
         </a>
         ]. Lung biopsy is rarely needed in SSc-associated ILD. (See
         <a class="medical medical_review" href="/z/d/html/4362.html" rel="external">
          "Interstitial lung disease in rheumatoid arthritis", section on 'Lung biopsy'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4368.html" rel="external">
          "Clinical manifestations, evaluation, and diagnosis of interstitial lung disease in systemic sclerosis (scleroderma)", section on 'Evaluation'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H689027266">
         <span class="h3">
          Interstitial lung disease presenting with acute respiratory failure
         </span>
         <span class="headingEndMark">
          —
         </span>
         For patients with acute respiratory failure due to an ILD with a rapidly progressive or accelerated course or an acute exacerbation of underlying ILD, a lung biopsy may be the only diagnostic modality likely to reveal a treatable diagnosis. However, most surgical biopsies in such patients do not lead to a better outcome due to diagnostic and therapeutic limitations and the increased perioperative morbidity and mortality of the procedure. (See
         <a class="local">
          'Morbidity and mortality'
         </a>
         below.)
        </p>
        <p>
         Most surgical lung biopsy data in patients with respiratory failure come from patients with acute respiratory distress syndrome (ARDS) and immunocompromised patients with pulmonary opacities and respiratory failure [
         <a href="#rid37">
          37-51
         </a>
         ]. Infection and malignancy are the most common specific diagnoses made on surgical lung biopsy in these patients. Given the high likelihood of infection or malignancy, it is worth considering whether a less invasive method would yield a diagnosis. Bronchoalveolar lavage (BAL) identifies the majority of pulmonary infections and has high sensitivity and negative predictive value with performance characteristics comparable with that of surgical lung biopsy to exclude pulmonary infections [
         <a href="#rid43">
          43,49,52,53
         </a>
         ]. Diffusely metastatic pulmonary malignancy can often be diagnosed with transbronchial biopsy.
        </p>
        <p>
         When a lung biopsy reveals a noninfectious and nonmalignant diagnosis, the diagnosis may not be useful therapeutically. Noninfectious and nonmalignant diagnoses are often reported using nonspecific terms such as fibrosis, nonspecific pneumonitis, chronic pneumonitis, interstitial fibrosis, interstitial pneumonitis, and interstitial pulmonary fibrosis that are insufficient to guide specific therapy [
         <a href="#rid37">
          37-51
         </a>
         ].
        </p>
        <p>
         Acute exacerbations of fibrotic interstitial lung diseases have been described in idiopathic pulmonary fibrosis (IPF), rheumatic disease-associated UIP or NSIP, idiopathic NSIP, chronic hypersensitivity pneumonitis, desquamative interstitial pneumonia (DIP), and asbestosis. The patients' clinical presentation is with an acute/subacute worsening of symptoms and hypoxemia. The diagnosis of acute exacerbation of ILD is based on exclusion, primarily of infection, heart failure, drugs, or aspiration. Biopsies from such patients generally show diffuse alveolar damage or organizing pneumonia superimposed on an underlying fibrotic process, which can often be hard to diagnose because of the acute findings [
         <a href="#rid54">
          54,55
         </a>
         ]. Additionally, it is unclear that a biopsy would affect therapeutic decisions in these patients because acute exacerbations of IPF and other ILDs are often treated with high-dose glucocorticoids irrespective of the biopsy results and generally have poor outcomes despite treatment [
         <a href="#rid54">
          54,56-62
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/110885.html" rel="external">
          "Acute exacerbations of idiopathic pulmonary fibrosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2780593358">
         <span class="h2">
          Radiologic pattern and decision to perform lung biopsy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Radiologic pattern on HRCT is an important consideration when deciding whether a patient should undergo a surgical lung biopsy [
         <a href="#rid63">
          63,64
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4358.html" rel="external">
          "Approach to the adult with interstitial lung disease: Diagnostic testing", section on 'Computed tomography'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/14870.html" rel="external">
          "Clinical manifestations and diagnosis of idiopathic pulmonary fibrosis", section on 'How to decide whether a biopsy is necessary'
         </a>
         .)
        </p>
        <p>
         The following considerations regarding the role of invasive lung biopsy apply to patients whose interstitial lung disease remains undiagnosed despite a thorough multidisciplinary assessment (see
         <a class="medical medical_review" href="/z/d/html/16921.html" rel="external">
          "Interpretation of lung biopsy results in interstitial lung disease"
         </a>
         ):
        </p>
        <p class="headingAnchor" id="H2573376049">
         <span class="h3">
          UIP pattern
         </span>
         <span class="headingEndMark">
          —
         </span>
         A UIP pattern demonstrates basal predominant (occasionally diffuse) and subpleural predominant, often heterogeneous reticular opacities with peripheral traction bronchiectasis or bronchiolectasis, honeycombing, and absence of features to suggest an alternative diagnosis [
         <a href="#rid63">
          63,64
         </a>
         ]. A UIP pattern on HRCT is very specific in predicting a UIP pattern on histopathology. A lung biopsy is therefore not recommended in patients with a UIP pattern on CT [
         <a href="#rid63">
          63,64
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3125257575">
         <span class="h3">
          Probable UIP pattern
         </span>
         <span class="headingEndMark">
          —
         </span>
         The "probable" UIP pattern on HRCT is similar to that of a UIP pattern except honeycombing is absent, ie, reticular opacities are predominantly basal and subpleural, with peripheral traction bronchiectasis or bronchiolectasis and a heterogeneous distribution [
         <a href="#rid63">
          63,64
         </a>
         ]. Features suggestive of an alternative diagnosis are notably absent.
        </p>
        <p>
         The 2022 American Thoracic Society (ATS), European Respiratory Society (ERS), Japanese Respiratory Society (JRS), and Latin American Thoracic Society (ALAT) guidelines suggest that a lung biopsy is
         <strong>
          not
         </strong>
         necessary in patients with an HRCT pattern considered definite or probable for UIP when a multidisciplinary discussion yields a confident diagnosis of IPF [
         <a href="#rid65">
          65
         </a>
         ]. This approach requires an assessment of both the HRCT pattern and the larger clinical context.
        </p>
        <p>
         In our clinical practice, we divide patients with a probable UIP pattern into two categories based on the pretest probability of IPF, confidence in the radiologic interpretation, and the estimated risk of postoperative morbidity and mortality from a surgical lung biopsy.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         We do not perform a surgical lung biopsy in patients who have a high pretest probability of IPF (for example, an older male smoker without other risk factors for ILD), when the HRCT pattern is made with high confidence, and when the estimated risk for postoperative morbidity and mortality is high because of comorbidities or severe physiologic restriction.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         We offer surgical lung biopsy to our patients with a probable UIP pattern on HRCT when the pretest probability of IPF is lower (for example, a younger patient with potential risk factors for another cause of ILD), and when the estimated risk for postoperative morbidity and mortality is low (absence of significant comorbidities and severe physiologic restriction). It is not uncommon for us to find alternative pathology such as hypersensitivity pneumonitis on the biopsy in these patients.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4023949570">
         <span class="h3">
          Indeterminate UIP pattern
         </span>
         <span class="headingEndMark">
          —
         </span>
         The opacities in the "indeterminate" UIP pattern are variable or diffuse, and there is evidence of fibrosis with some inconspicuous features suggestive of non-UIP pattern. The indeterminate UIP radiographic pattern is neither sensitive nor specific for UIP or other alternative findings on histopathology, and a surgical lung biopsy should be considered if a specific diagnosis cannot otherwise be made, unless contraindications are present [
         <a href="#rid63">
          63,64
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3883724293">
         <span class="h3">
          Radiologic pattern suggestive of alternative diagnosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         The previous label of "not UIP" pattern has been changed to pattern suggestive of an "alternative diagnosis" because a subset of patients with a histopathologic finding of UIP have CT patterns that suggest non-IPF diagnoses [
         <a href="#rid63">
          63,64
         </a>
         ]. These radiologic findings include upper-lung or mid-lung predominant fibrosis, peribronchovascular predominance with subpleural sparing, predominant consolidation, extensive ground-glass opacity (without acute exacerbation), extensive mosaic attenuation with sharply defined lobular air trapping on expiration, and diffuse nodules or cysts. A surgical lung biopsy should be offered to patients with this radiologic pattern if a specific diagnosis cannot otherwise be made, unless contraindications are present [
         <a href="#rid63">
          63,64
         </a>
         ].
        </p>
        <p>
         In the uncommon situation where the radiologic pattern shows extensive fibrosis and architectural distortion (and does not have any of the other features described above such as ground-glass opacities), a surgical lung biopsy is generally not indicated because it is unlikely to alter management.
        </p>
        <p class="headingAnchor" id="H2761863923">
         <span class="h1">
          TRANSBRONCHIAL CRYOBIOPSY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Transbronchial cryobiopsy (cryo-TBB), which is performed under moderate sedation or general anesthesia, is a technique to obtain biopsy samples of lung parenchyma that exceed the size and quality of forceps biopsy samples [
         <a href="#rid66">
          66-72
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H301892840">
         <span class="h2">
          Procedure
         </span>
         <span class="headingEndMark">
          —
         </span>
         Cryobiopsies are obtained using a specialized, flexible probe that uses
         <a class="drug drug_general" data-topicid="10086" href="/z/d/drug information/10086.html" rel="external">
          nitrous oxide
         </a>
         to rapidly cool the tip to -89˚C, thus freezing adjacent tissue that is then removed attached to the tip of the probe. Cryo-TBB yields larger size biopsy specimens (43 to 64 mm
         <sup>
          2
         </sup>
         ) compared with transbronchial biopsy (5.8 mm
         <sup>
          2
         </sup>
         , range 0.58 to 20.88 mm
         <sup>
          2
         </sup>
         ) without crush artifacts, and therefore appears more likely to yield diagnostic information in support of a specific ILD [
         <a href="#rid66">
          66,73,74
         </a>
         ]. The accuracy of cryo-TBB samples improves considerably when two or more samples are reviewed (instead of only one) and when biopsy is obtained in two different sites (instead of only one site), either from the same lobe or from different lobes (obtaining samples from different lobes is advised when there is inter-lobar radiographic heterogeneity) [
         <a href="#rid75">
          75
         </a>
         ].
        </p>
        <p>
         Additional study is needed to clarify procedural issues such as the optimal duration of freezing time, the distance from the pleural to optimize safety and yield, and also the number of segments and ipsilateral lobes that can be safely biopsied in one procedure [
         <a href="#rid70">
          70,72,76,77
         </a>
         ]. The procedure is described in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/106085.html" rel="external">
          "Flexible bronchoscopy in adults: Associated diagnostic and therapeutic procedures", section on 'Transbronchial biopsy'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4407.html" rel="external">
          "Bronchoscopic cryotechniques in adults", section on 'Cryobiopsy'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2393218503">
         <span class="h2">
          When is cryo-TBB most helpful?
         </span>
         <span class="headingEndMark">
          —
         </span>
         International guidelines stress that the use of cryo-TBB for the diagnosis of ILD should only be performed in high-volume centers with standardized protocols to minimize risk and maximize yield, as well as experienced personnel for performing biopsies and providing pathologic interpretation of small samples [
         <a href="#rid65">
          65,78
         </a>
         ]. In these centers of expertise, cryo-TBB offers the possibility of improved safety and only modestly decreased diagnostic yield compared with surgical approaches [
         <a href="#rid67">
          67,68,79-81
         </a>
         ]. We do not consider cryo-TBB to be a replacement for the currently accepted gold standard for diagnosis of ILD, ie, surgical lung biopsy with multidisciplinary discussion and consensus diagnosis [
         <a href="#rid31">
          31,36
         </a>
         ].
        </p>
        <p>
         Although larger pieces of tissue can be obtained with cryobiopsy than Transbronchial lung biopsies (TBLB), some limitations of the bronchoscopic approach remain. These include nondiagnostic samples in patchy disease or when pleural/subpleural pathology adds critical diagnostic information [
         <a href="#rid82">
          82
         </a>
         ]. We therefore reserve cryo-TBB for central, peribronchial, or diffuse interstitial processes. Cryo-TBB results should also be reviewed in the context of multidisciplinary discussion to establish a specific ILD diagnosis. Subsequent surgical lung biopsy may be appropriate in patients who have nondiagnostic cryo-TBB samples. (See
         <a class="medical medical_review" href="/z/d/html/14870.html" rel="external">
          "Clinical manifestations and diagnosis of idiopathic pulmonary fibrosis", section on 'Multidisciplinary discussion and next steps'
         </a>
         .)
        </p>
        <p>
         Cryo-TBB may also be helpful with occasional patients at high risk for adverse events with surgical lung biopsy, but for whom histopathologic information is highly likely to change management. One study compared adverse outcomes after cryo-TBB in 58 patients at low risk for surgical lung biopsy (SLB) and 38 patients with high risk of SLB based on age ≥75 years, body mass index (BMI) ≥35 kg·m
         <sup>
          −2
         </sup>
         , systolic pulmonary arterial pressure (sPAP) by echocardiography ≥45 mmHg, forced vital capacity (FVC) &lt;50 percent, diffusing capacity of the lung for carbon monoxide (
         <em>
          D
         </em>
         <sub>
          LCO
         </sub>
         ) &lt;30 percent and/or heart failure with reduced ejection fraction [
         <a href="#rid83">
          83
         </a>
         ]. Bleeding, pneumothorax, mortality and length of hospital stay were equal between the two groups.
        </p>
        <p>
         However, the advantages of potentially increasing diagnostic certainty should be carefully weighed against the potential for adverse events. This is particularly true in patients with critical illness or rapidly progressive ILD, for whom procedural risk is higher than for patients with chronic comorbidities. (See
         <a class="local">
          'Interstitial lung disease presenting with acute respiratory failure'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H35246760">
         <span class="h2">
          Comparison with surgical lung biopsy
         </span>
        </p>
        <p class="headingAnchor" id="H673152087">
         <span class="h3">
          Diagnostic yield
         </span>
         <span class="headingEndMark">
          —
         </span>
         In general, the diagnostic yield of cryo-TBB is less than with SLB (approximately 80 percent compared with 90 percent for SLB), although study results vary [
         <a href="#rid71">
          71,79,82,84,85
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Two studies have directly compared cryo-TBB and SLB yields. The COLDICE prospective study obtained both cryo-TBB and SLB specimens from 65 patients with ILD and found histopathologic concordance in 70 percent [
         <a href="#rid82">
          82
         </a>
         ]. Low-confidence or unclassifiable cryo-TBB diagnoses were reported in 26 patients (40 percent) and of these SLB reclassified six (23 percent) to alternative high-confidence or definite diagnoses after multidisciplinary discussion (MDD). In a separate study comparing cryo-TBB with SLB, pathological results were discordant in 11 of 21 patients (52 percent) [
         <a href="#rid84">
          84
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a prospective, multicenter study of 128 patients with suspected idiopathic interstitial pneumonia, cryo-TBB increased the frequency of high confidence in the diagnosis (≥70 percent likelihood) from 60 to 81 percent, and the frequency of a confident diagnosis (≥90 percent likelihood) from 23 percent after bronchoalveolar lavage to 54 percent after cryo-TBB [
         <a href="#rid71">
          71
         </a>
         ]. Cryo-TBB was complicated by pneumothorax in 21 patients (16.4 percent) and moderate to severe bleeding in 20 patients (15.7 percent).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In one single-center prospective cohort study of 141 patients with unclassifiable ILD after multidisciplinary discussion, outpatient cryo-TBB facilitated a pathologic diagnosis in 75 percent of patients and a clinical diagnosis (after multidisciplinary discussion) in 88 percent [
         <a href="#rid86">
          86
         </a>
         ]. Idiopathic interstitial pneumonias constituted the majority (67.3 percent) of the clinical diagnoses.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a retrospective study of 699 patients with diffuse parenchymal lung disease, a specific diagnosis was determined by cryo-TBB in 88 percent and a MDD diagnosis in 90 percent [
         <a href="#rid75">
          75
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1331481998">
         <span class="h3">
          Safety
         </span>
         <span class="headingEndMark">
          —
         </span>
         While the procedure is generally free of major complications [
         <a href="#rid73">
          73
         </a>
         ], pneumothorax (2.6 to 30 percent), moderate bleeding (4 to 78 percent), ILD exacerbation, and rarely death (0.3 to 1.4 percent) have been reported [
         <a href="#rid67">
          67,68,71,74,82,87-94
         </a>
         ]. In the single-center study described above (n = 141), cryo-TBB was complicated by pneumothorax in 21 patients (14.9 percent), moderate bleeding in 20 patients (15.7 percent), and two deaths (1.4 percent) within 30 days of cryo-TBB [
         <a href="#rid86">
          86
         </a>
         ].
        </p>
        <p>
         Despite the reported complications, the procedure is generally safer than SLB [
         <a href="#rid72">
          72
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h1">
          SURGICAL LUNG BIOPSY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Surgical lung biopsy (SLB) specimens can be obtained by video assisted thoracoscopic surgery (VATS) or thoracotomy [
         <a href="#rid95">
          95,96
         </a>
         ]. Surgical specimens are substantially larger than those obtained by transbronchial lung biopsy (TBLB). Reported diagnostic yields vary, but are in the range of 85 to 92 percent [
         <a href="#rid5">
          5,95-98
         </a>
         ]. In general the choice of procedure is based on the surgeon's expertise and preference, although thoracotomy is occasionally required instead of VATS because of severe pleural disease, anticipated bleeding, or more severe respiratory impairment. When SLB is necessary in patients with severe hypoxemia or requiring mechanical ventilation, thoracotomy is generally preferred because one lung ventilation is not absolutely necessary, whereas VATS requires a period of one lung ventilation. (See
         <a class="medical medical_review" href="/z/d/html/15141.html" rel="external">
          "Overview of minimally invasive thoracic surgery"
         </a>
         .)
        </p>
        <p>
         Ideally, SLB is performed prior to the initiation of systemic glucocorticoids or other immunosuppressive therapy [
         <a href="#rid5">
          5
         </a>
         ]. However, a biopsy can often provide a histopathologic diagnosis after initiation of such therapies [
         <a href="#rid99">
          99
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1746688650">
         <span class="h2">
          Surgical approach
         </span>
         <span class="headingEndMark">
          —
         </span>
         Surgical lung biopsy specimens can be obtained via video assisted thoracoscopic surgery (VATS) or thoracotomy. The choice between these procedures is typically determined by the expertise and preference of the thoracic surgeon, although the majority are performed by VATS. While VATS appears to be associated with less morbidity overall, thoracotomy may be preferred in the setting of severe pleural disease, a bleeding diathesis, or mechanical ventilation.
        </p>
        <p class="headingAnchor" id="H5484649">
         <span class="h3">
          VATS
         </span>
         <span class="headingEndMark">
          —
         </span>
         VATS is a minimally invasive form of thoracic surgery performed under general anesthesia. One lung ventilation is employed during the biopsy procedure, so the lung being biopsied is deflated and respiratory movement inhibited. A rigid or semi-rigid thoracoscope and forceps for lung biopsy are typically introduced into the pleural space through one or two small incisions usually on the lateral chest wall. (See
         <a class="medical medical_review" href="/z/d/html/15141.html" rel="external">
          "Overview of minimally invasive thoracic surgery"
         </a>
         and
         <a class="local">
          'One lung ventilation'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H5484684">
         <span class="h3">
          Thoracotomy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Thoracotomy, also performed under general anesthesia, requires a surgical incision of 5 to 6 cm. One lung ventilation can be used during the procedure, so the lung being biopsied is deflated and respiratory movement inhibited.
        </p>
        <p>
         Alternatively, for patients with more advanced lung disease or those on mechanical ventilation who cannot tolerate single lung ventilation, lung biopsy can be obtained through a thoracotomy incision without deflation of the lung being biopsied. The thoracotomy incision allows the surgeon to palpate the lung texture but does not necessarily allow biopsy of areas of the lung remote from the incision.
        </p>
        <p class="headingAnchor" id="H979589">
         <span class="h3">
          VATS versus thoracotomy
         </span>
         <span class="headingEndMark">
          —
         </span>
         VATS is preferred over thoracotomy because morbidity appears to be less with VATS [
         <a href="#rid2">
          2,100-102
         </a>
         ]. Specimen adequacy and diagnostic accuracy are the same with the two procedures, although it is technically easier to obtain multilobe lung biopsies by VATS than by thoracotomy [
         <a href="#rid5">
          5,100
         </a>
         ]. On the other hand, thoracotomy may be preferred in the presence of patient factors such as extensive pleural disease, bleeding disorder, and severe respiratory impairment causing inability to tolerate one lung ventilation.
        </p>
        <p>
         Data from small trials suggest that morbidity and mortality are the same or slightly lower for VATS compared with thoracotomy [
         <a href="#rid103">
          103,104
         </a>
         ]. A prospective, randomized trial comparing the two procedures found no difference in morbidity or mortality, however the study was small (42 patients) [
         <a href="#rid103">
          103
         </a>
         ]. A separate randomized trial of 61 patients reported reduced need for postoperative analgesia, shorter duration of chest tube drainage, and shorter hospital stay with VATS, but no difference in diagnostic yield or complication rates [
         <a href="#rid104">
          104
         </a>
         ].
        </p>
        <p>
         Looking at case series, complication rates and mortality are the same or lower for VATS than for thoracotomy, but the actual difference is likely less than the reported rates for several reasons. First, almost all of these data are retrospective and thoracotomy may have been performed instead of VATS because pleural adhesions or severe hypoxemia preclude the single lung ventilation needed for VATS. Such patients are likely to be at higher risk of complications and mortality. Second, most of the thoracotomy data comes from before 1992 and most of the VATS data comes from after 1992; improvement in intraoperative and postoperative care possibly contributed in some measure to the difference in mortalities. Third, most immunocompromised patients with respiratory failure, the group with the highest mortality, underwent thoracotomy instead of VATS, further skewing the mortality and complication rates in favor of VATS.
        </p>
        <p class="headingAnchor" id="H2135210179">
         <span class="h2">
          One lung ventilation
         </span>
         <span class="headingEndMark">
          —
         </span>
         One lung ventilation (also known as single lung ventilation) is used during most surgical lung biopsy procedures to deflate the lung being biopsied for visualization and access. The transition from dual to one lung ventilation requires a balance between providing adequate ventilation to avoid hypoxemia and hypercapnia and preventing volutrauma and barotrauma caused by high tidal volumes or high plateau pressures. Lung protective ventilation is a key component of this process. (See
         <a class="medical medical_review" href="/z/d/html/14945.html" rel="external">
          "One lung ventilation: General principles"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1592.html" rel="external">
          "Diagnosis, management, and prevention of pulmonary barotrauma during invasive mechanical ventilation in adults"
         </a>
         .)
        </p>
        <p>
         The importance of the lung protective ventilation is evident in the observation that patients are more likely to develop postoperative noncardiogenic pulmonary edema in the lung contralateral to the biopsy/resection site, ie, the ventilated lung rather than the collapsed lung. While the exact mechanism is not known, the predilection for the contralateral side suggests that ventilator-induced lung injury during the one lung ventilation may play a role [
         <a href="#rid105">
          105-107
         </a>
         ]. In theory, intraoperative low tidal volume ventilation with maintenance of a low plateau pressure may be protective. The technique of one lung ventilation is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/14945.html" rel="external">
          "One lung ventilation: General principles"
         </a>
         .)
        </p>
        <p>
         Due to poor lung compliance in patients with pulmonary fibrosis, increasing the positive end-expiratory pressure (PEEP) may not lead to lung recruitment and improved ventilation [
         <a href="#rid108">
          108
         </a>
         ]. Careful attention to keeping the plateau pressure to a minimum level required for adequate oxygenation is essential when increasing PEEP in response to hypoxemia. (See
         <a class="medical medical_review" href="/z/d/html/94363.html" rel="external">
          "Anesthesia for patients with interstitial lung disease or other restrictive disorders"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h2">
          Specimen collection
         </span>
         <span class="headingEndMark">
          —
         </span>
         The optimal number, size, and location of lung biopsies depend upon the suspected diagnosis and the anatomic distribution of the disease process. The clinician should communicate to the thoracic surgeon any specific concerns and suggestions regarding these issues. HRCT imaging plays an essential role in selecting the best location(s) to biopsy [
         <a href="#rid99">
          99,109
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6988.html" rel="external">
          "High resolution computed tomography of the lungs"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Involved, but not fibrotic areas
         </strong>
         – Regions that appear completely normal should be avoided, just as regions of greatest involvement and honeycombing should be avoided because biopsy from the latter sites generally reveals end stage fibrosis with little diagnostic value [
         <a href="#rid110">
          110,111
         </a>
         ]. Lung parenchyma with mild involvement or lung parenchyma adjacent to obviously abnormal areas should be biopsied [
         <a href="#rid109">
          109
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Multilobar biopsies
         </strong>
         – Ideally, biopsies are obtained from more than one lobe of the lung and from areas of varying severity, as several studies suggest that this improves diagnostic accuracy [
         <a href="#rid5">
          5,112
         </a>
         ]. In a retrospective study examining explanted lungs in 20 patients with UIP, areas resembling NSIP were seen in 16 of 20 explant specimens [
         <a href="#rid113">
          113
         </a>
         ]. In 28 of 109 (26 percent) patients with usual or nonspecific interstitial pneumonia, the histopathology in at least one lobe was discordant from another lobe (NSIP in one lobe and UIP in the other) [
         <a href="#rid114">
          114
         </a>
         ]. The outcomes in patients with NSIP-UIP discordant biopsy results were similar to patients with concordant UIP-UIP biopsy results, and significantly worse than patients with NSIP-NSIP concordant biopsy results [
         <a href="#rid114">
          114,115
         </a>
         ]. This distinction, which has important prognostic and therapeutic implications, cannot be made without multiple biopsies from more than one lobe. In a separate series of 24 patients, the diagnostic yield was improved by multilobe biopsies in one-third [
         <a href="#rid25">
          25
         </a>
         ]. Among 15 patients with chronic hypersensitivity pneumonitis, sampling from more than one lobe helped to identify hypersensitivity pneumonitis in two patients who had chronic hypersensitivity pneumonitis on biopsies from one lobe and UIP on biopsies from another lobe [
         <a href="#rid116">
          116
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Lingular biopsy
         </strong>
         – Some of the older literature cautions against biopsy from the tip of the lingula but this has not been borne out in more recent studies because the diagnostic yield from lingular biopsies has been comparable to those from other lobes, and there is no reason to avoid the lingula if it is considered to be a good site based on the HRCT [
         <a href="#rid5">
          5,99,110,117-119
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Size of biopsy
         </strong>
         – In order to provide the pathologist with adequate tissue to evaluate the pattern and distribution of disease, lung biopsy samples are ideally greater than 4 cm in the greatest dimension when inflated and include a depth from the pleural surface of 3 to 5 cm [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2317981517">
         <span class="h2">
          Morbidity and mortality
         </span>
         <span class="headingEndMark">
          —
         </span>
         Data on morbidity and mortality related to surgical lung biopsy for ILD vary widely depending on the source of the data, severity of respiratory impairment, type of lung disease, and age and sex of the patient. The largest analysis, of approximately 12,000 surgical lung biopsies, used a national database of a stratified sample of United States hospitals detailing diagnoses and procedure codes from 2000 to 2010 [
         <a href="#rid120">
          120
         </a>
         ]. In-hospital mortality was under 2 percent for elective procedures, which comprised two-thirds of the surgical lung biopsies for this period, and 16 percent for nonelective biopsies, which comprised the remaining one-third. Factors associated with an increased mortality were male sex, older age, comorbid conditions, thoracotomy, and a provisional diagnosis of idiopathic pulmonary fibrosis or rheumatic disease-related interstitial lung disease. (See
         <a class="local">
          'When is lung biopsy unlikely to be helpful?'
         </a>
         above.)
        </p>
        <p>
         Individual case series report a wide variation in mortality following surgical lung biopsy [
         <a href="#rid10">
          10,25,37,67,95,96,121,122
         </a>
         ]. The characteristics of the patient population appear to be the primary determinant of mortality in patients undergoing a surgical lung biopsy [
         <a href="#rid123">
          123
         </a>
         ]. An increasing number and severity of comorbidities, severe physiologic restriction, immunosuppressed state, underlying solid or hematologic malignancy, and respiratory failure are all associated with increased mortality. The case series reporting highest mortality post-surgical lung biopsy (13 to 70 percent) have a high proportion of patients with various combinations of these risk factors [
         <a href="#rid123">
          123
         </a>
         ]. However, even in series reporting a very high mortality, only a small proportion of deaths are directly attributed to the procedure itself by the authors. Series not including patients with these high risk factors report very low or no mortality [
         <a href="#rid10">
          10
         </a>
         ]. The following observations demonstrate the impact of these factors.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Preoperative hypoxemia
         </strong>
         – The presence and degree of preoperative hypoxemia correlate with progressively worse outcomes in patients with ILD undergoing surgical lung biopsy. No mortality and little morbidity were noted in studies of ambulatory patients and those without significant hypoxemia [
         <a href="#rid124">
          124-129
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         In a retrospective study of 48 patients undergoing surgical lung biopsy, the mortality was 4.2 percent for patients without hypoxemia, 6 percent for patients on supplemental oxygen, 60 percent for patients with severe hypoxemia and respiratory distress, and 75 percent for patients who were receiving invasive mechanical ventilation [
         <a href="#rid127">
          127
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         In a study of 68 ambulatory patients with interstitial lung disease referred for a VATS lung biopsy, patients receiving supplemental oxygen were 21 times more likely to develop significant postoperative complications [
         <a href="#rid128">
          128
         </a>
         ]. In this study, an analysis of 22 previously published studies showed that patients with interstitial lung disease requiring preoperative mechanical ventilation were significantly more likely to die postoperatively when compared with patients who did not (47 versus 2 percent).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         In a study of 194 patients with ILD who underwent surgical lung biopsy, the mortality was 0 percent in patients without preoperative hypoxemia, 4.8 percent for patients without respiratory failure, and 100 percent for patients with ILD and preoperative respiratory failure [
         <a href="#rid129">
          129
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Acute exacerbation or rapid progression of ILD
         </strong>
         – Patients with an exacerbation or rapid progression of their ILD at the time of biopsy are at a particularly high risk of perioperative complications and death.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         In a series reporting outcomes in 60 patients with IPF undergoing surgical lung biopsy, 7 of the 10 IPF patients who died after a surgical lung biopsy were experiencing an acute exacerbation of IPF at the time of the biopsy [
         <a href="#rid56">
          56
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         In a series of 200 patients with idiopathic ILDs undergoing surgical lung biopsy, patients experiencing an acute exacerbation were 10 times more likely to die after a surgical lung biopsy, than patients without an acute exacerbation (28.6 versus 3 percent mortality) [
         <a href="#rid130">
          130
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         In a series of 76 patients with UIP, all four of the patients who died had diffuse alveolar damage superimposed on UIP [
         <a href="#rid102">
          102
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         However, these postoperative deaths need to be interpreted in the context that patients with IPF exacerbation have a very high mortality irrespective of whether not they undergo a surgical lung biopsy [
         <a href="#rid54">
          54,56-62
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/110885.html" rel="external">
          "Acute exacerbations of idiopathic pulmonary fibrosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4658163">
         <span class="h1">
          PROCESSING LUNG BIOPSY SPECIMENS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Lung biopsy specimens are sent for histopathologic analysis, accompanied by clinical information for the pathologist including the suspected diagnosis or differential diagnosis. If the patient is immunosuppressed or infection is suspected (eg, fever, short duration of symptoms), samples are sent for mycobacterial, fungal, and viral studies. Sending surgical biopsy specimens routinely for microbiologic testing is not necessary in patients with interstitial lung disease because culture results in this group of patients are rarely useful clinically [
         <a href="#rid115">
          115,131
         </a>
         ].
        </p>
        <p>
         Frozen sections are generally not useful in the diagnosis of diffuse parenchymal lung disease but may be used during surgical biopsy to assess whether an adequate sample has been obtained or when malignancy is suspected.
        </p>
        <p>
         As the sample size is small, the entirety of transbronchial biopsy or transbronchial cryobiopsy specimens not sent to microbiology should be processed and examined. Surgical lung biopsy specimens are gently inflated by injection of formalin prior to sectioning to facilitate visualization of the interstitium [
         <a href="#rid5">
          5,132
         </a>
         ]. Overinflation however must be avoided as this may cause loss of pathologic features, such as washing out macrophages from the alveolar spaces. For diffuse parenchymal lung disease, the routine initial stain is hematoxylin and eosin; additional staining to help assess the extent of fibrosis and elastosis (eg, elastic van Gieson) should also be considered.
        </p>
        <p>
         Special stains are performed as indicated based on the clinical suspicion or initial findings. As examples, staining for CD1a is done when Langerhans cell histiocytosis is suspected, immunostaining for monoclonal populations may be indicated in specimens with a high proportion of lymphocytes, and special mycobacterial and fungal stains are done whenever granulomas are noted. Tissue can be stained with Congo red if amyloidosis is suspected clinically or based on radiologic or histopathologic appearance. Similarly, polarizing light is used to identify birefringent material when talcosis or pneumoconiosis is suspected. (See
         <a class="medical medical_review" href="/z/d/html/16921.html" rel="external">
          "Interpretation of lung biopsy results in interstitial lung disease", section on 'Langerhans cell granulomatosis'
         </a>
         .)
        </p>
        <p>
         Consultation with a pathologist familiar with the histopathological features of interstitial pneumonias and integration of clinical data in a multidisciplinary conference is highly recommended. The interpretation of lung biopsies obtained for diffuse parenchymal lung disease is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/16921.html" rel="external">
          "Interpretation of lung biopsy results in interstitial lung disease"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H167684397">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/118793.html" rel="external">
          "Society guideline links: Interstitial lung disease"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H9043950">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, “The Basics” and “Beyond the Basics.” The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on “patient info” and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Beyond the Basics topics (see
         <a class="medical medical_patient" href="/z/d/html/4645.html" rel="external">
          "Patient education: Flexible bronchoscopy (Beyond the Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topics (See
         <a class="medical medical_basics" href="/z/d/html/86972.html" rel="external">
          "Patient education: Interstitial lung disease (The Basics)"
         </a>
         and
         <a class="medical medical_basics" href="/z/d/html/83031.html" rel="external">
          "Patient education: Idiopathic pulmonary fibrosis (The Basics)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H20484825">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Diffuse parenchymal lung diseases, often collectively referred to as interstitial lung diseases (ILDs), are a heterogeneous group of disorders that are classified together because of similar clinical, radiographic, physiologic, or pathologic manifestations. An approach to evaluating immunocompetent adults with ILD is shown in the algorithm  (
         <a class="graphic graphic_algorithm graphicRef77345" href="/z/d/graphic/77345.html" rel="external">
          algorithm 1
         </a>
         ) and discussed in detail separately. (See
         <a class="local">
          'Introduction'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/4310.html" rel="external">
          "Approach to the adult with interstitial lung disease: Clinical evaluation"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4358.html" rel="external">
          "Approach to the adult with interstitial lung disease: Diagnostic testing"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Indications for lung biopsy in patients with ILD include atypical clinical features (age &lt;50 years, fever, weight loss, hemoptysis, signs of vasculitis); a progressive course; a normal, atypical, or rapidly changing chest radiograph or high-resolution CT scan (HRCT); unexplained extrapulmonary manifestations; or pulmonary vascular disease of unclear origin. (See
         <a class="local">
          'Overview'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Lung biopsy is less likely to be helpful in patients with a known systemic rheumatic (connective tissue) disease or with acute respiratory failure complicating ILD. (See
         <a class="local">
          'When is lung biopsy unlikely to be helpful?'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Flexible bronchoscopy with transbronchial lung biopsy (TBLB) is minimally invasive and is often the biopsy procedure of choice when sarcoidosis, hypersensitivity pneumonitis, lymphangitic carcinomatosis, eosinophilic pneumonia, alveolar proteinosis, or infection is suspected. (See
         <a class="local">
          'Transbronchial lung biopsy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         TBLB samples are a few millimeters in size and are likely to miss diseases that are patchy or require examination of a larger area of tissue for accurate diagnosis (eg, usual interstitial pneumonitis [UIP], nonspecific interstitial pneumonia [NSIP], vasculitis). (See
         <a class="local">
          'What are the diagnostic limitations?'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Typically, four to six TBLBs are obtained from areas of lung that appear involved radiographically. If the lungs are uniformly involved, the lower lobe or both upper and lower lobes are biopsied. All biopsies are obtained on the same side to avoid the risk of bilateral pneumothoraces. (See
         <a class="local">
          'Specimen collection and diagnostic yield'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Ancillary bronchoscopic tests such as endobronchial biopsy and bronchoalveolar lavage can help improve the diagnostic yield of TBLB. For patients with hilar or mediastinal adenopathy, endobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA) may contribute to the diagnostic yield, although general anesthesia and specialized equipment are required. (See
         <a class="local">
          'Ancillary tests'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/4303.html" rel="external">
          "Basic principles and technique of bronchoalveolar lavage"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4308.html" rel="external">
          "Role of bronchoalveolar lavage in diagnosis of interstitial lung disease"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Transbronchial cryobiopsy (cryo-TBB) is a bronchoscopic technique performed under moderate sedation or general anesthesia that is designed to obtain larger biopsy samples than TBLB. When performed in centers of expertise, Cryo-TBB may be an acceptable less invasive alternative to surgical lung biopsy (SLB) in patients with central, peribronchial, or diffuse interstitial processes based on improved safety and only modestly decreased diagnostic yield. (See
         <a class="local">
          'Transbronchial cryobiopsy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Surgical lung biopsy specimens can be obtained via video assisted thoracoscopic surgery (VATS) or thoracotomy; the choice between these procedures is typically determined by the expertise and preference of the thoracic surgeon. Thoracotomy may be preferred in the setting of severe pleural disease, a bleeding diathesis, or mechanical ventilation. (See
         <a class="local">
          'VATS versus thoracotomy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In order to provide the pathologist with adequate tissue to evaluate the pattern and distribution of disease, surgical biopsies should be greater than 4 cm in the greatest dimension when inflated and include a depth from the pleural surface of 3 to 5 cm. Ideally, specimens are obtained from more than one lobe of the lung. (See
         <a class="local">
          'Specimen collection'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         TBLB, cryo-TBB, and surgical lung biopsy specimens are sent for histopathologic analysis and, when indicated, mycobacterial, fungal, and viral testing. (See
         <a class="local">
          'Processing lung biopsy specimens'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Consultation with a pathologist familiar with the histopathological features of interstitial pneumonias and integration of clinical and radiologic data in a multidisciplinary conference is highly recommended. The interpretation of lung biopsy results in the context of the clinical setting is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/16921.html" rel="external">
          "Interpretation of lung biopsy results in interstitial lung disease"
         </a>
         .)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Poletti V, Chilosi M, Olivieri D. Diagnostic invasive procedures in diffuse infiltrative lung diseases. Respiration 2004; 71:107.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Halkos ME, Gal AA, Kerendi F, et al. Role of thoracic surgeons in the diagnosis of idiopathic interstitial lung disease. Ann Thorac Surg 2005; 79:2172.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nicholson AG, Fulford LG, Colby TV, et al. The relationship between individual histologic features and disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2002; 166:173.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vaszar LT, Larsen BT, Swanson KL, et al. Diagnostic utility of surgical lung biopsies in elderly patients with indeterminate interstitial lung disease. Respirology 2018; 23:507.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bradley B, Branley HM, Egan JJ, et al. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax 2008; 63 Suppl 5:v1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ensminger SA, Prakash UB. Is bronchoscopic lung biopsy helpful in the management of patients with diffuse lung disease? Eur Respir J 2006; 28:1081.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leslie KO, Gruden JF, Parish JM, Scholand MB. Transbronchial biopsy interpretation in the patient with diffuse parenchymal lung disease. Arch Pathol Lab Med 2007; 131:407.
          </a>
         </li>
         <li class="breakAll">
          Cosgrove GP, Schwarz MI. Approach to the evaluation and diagnosis of interstitial lung disease. In: Interstitial Lung Disease, 5th, Schwarz MI, King TE, Jr (Eds), People's Medical Publishing House, Shelton, CT 2011. p.3.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sehgal IS, Bal A, Dhooria S, et al. A Prospective Randomized Controlled Trial Comparing the Efficacy and Safety of Cup vs Alligator Forceps for Performing Transbronchial Lung Biopsy in Patients With Sarcoidosis. Chest 2016; 149:1584.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Raj R, Raparia K, Lynch DA, Brown KK. Surgical Lung Biopsy for Interstitial Lung Diseases. Chest 2017; 151:1131.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Glaspole IN, Wells AU, du Bois RM. Lung biopsy in diffuse parenchymal lung disease. Monaldi Arch Chest Dis 2001; 56:225.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cottin V, Cordier JF. Cryptogenic organizing pneumonia. Semin Respir Crit Care Med 2012; 33:462.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Berbescu EA, Katzenstein AL, Snow JL, Zisman DA. Transbronchial biopsy in usual interstitial pneumonia. Chest 2006; 129:1126.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tomassetti S, Cavazza A, Colby TV, et al. Transbronchial biopsy is useful in predicting UIP pattern. Respir Res 2012; 13:96.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shim HS, Park MS, Park IK. Histopathologic findings of transbronchial biopsy in usual interstitial pneumonia. Pathol Int 2010; 60:373.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183:788.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Churg A, Schwarz M. Transbronchial biopsy and usual interstitial pneumonia: a new paradigm? Chest 2006; 129:1117.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sindhwani G, Shirazi N, Sodhi R, et al. Transbronchial lung biopsy in patients with diffuse parenchymal lung disease without 'idiopathic pulmonary fibrosis pattern' on HRCT scan - Experience from a tertiary care center of North India. Lung India 2015; 32:453.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Descombes E, Gardiol D, Leuenberger P. Transbronchial lung biopsy: an analysis of 530 cases with reference to the number of samples. Monaldi Arch Chest Dis 1997; 52:324.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Curley FJ, Johal JS, Burke ME, Fraire AE. Transbronchial lung biopsy: can specimen quality be predicted at the time of biopsy? Chest 1998; 113:1037.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jabbardarjani H, Eslaminejad A, Mohammadtaheri Z, et al. The effect of cup versus alligator forceps on the results of transbronchial lung biopsy. J Bronchology Interv Pulmonol 2010; 17:117.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Boer S, Milne DG, Zeng I, Wilsher ML. Does CT scanning predict the likelihood of a positive transbronchial biopsy in sarcoidosis? Thorax 2009; 64:436.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Halme M, Piilonen A, Taskinen E. Comparison of endobronchial and transbronchial biopsies with high-resolution CT (HRCIT) in the diagnosis of sarcoidosis. APMIS 2001; 109:289.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roethe RA, Fuller PB, Byrd RB, Hafermann DR. Transbronchoscopic lung biopsy in sarcoidosis. Optimal number and sites for diagnosis. Chest 1980; 77:400.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vansteenkiste J, Verbeken E, Thomeer M, et al. Medical thoracoscopic lung biopsy in interstitial lung disease: a prospective study of biopsy quality. Eur Respir J 1999; 14:585.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bjermer L, Thunell M, Rosenhall L, Stjernberg N. Endobronchial biopsy positive sarcoidosis: relation to bronchoalveolar lavage and course of disease. Respir Med 1991; 85:229.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nakajima T, Yasufuku K, Kurosu K, et al. The role of EBUS-TBNA for the diagnosis of sarcoidosis--comparisons with other bronchoscopic diagnostic modalities. Respir Med 2009; 103:1796.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fischer A, Swigris JJ, Groshong SD, et al. Clinically significant interstitial lung disease in limited scleroderma: histopathology, clinical features, and survival. Chest 2008; 134:601.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bouros D, Wells AU, Nicholson AG, et al. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 2002; 165:1581.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moore OA, Goh N, Corte T, et al. Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease. Rheumatology (Oxford) 2013; 52:155.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Winstone TA, Assayag D, Wilcox PG, et al. Predictors of mortality and progression in scleroderma-associated interstitial lung disease: a systematic review. Chest 2014; 146:422.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nakamura Y, Suda T, Kaida Y, et al. Rheumatoid lung disease: prognostic analysis of 54 biopsy-proven cases. Respir Med 2012; 106:1164.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Park JH, Kim DS, Park IN, et al. Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. Am J Respir Crit Care Med 2007; 175:705.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fischer A, Brown KK, Du Bois RM, et al. Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease. J Rheumatol 2013; 40:640.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Assayag D, Elicker BM, Urbania TH, et al. Rheumatoid arthritis-associated interstitial lung disease: radiologic identification of usual interstitial pneumonia pattern. Radiology 2014; 270:583.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tsuchiya Y, Takayanagi N, Sugiura H, et al. Lung diseases directly associated with rheumatoid arthritis and their relationship to outcome. Eur Respir J 2011; 37:1411.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Patel SR, Karmpaliotis D, Ayas NT, et al. The role of open-lung biopsy in ARDS. Chest 2004; 125:197.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Warner DO, Warner MA, Divertie MB. Open lung biopsy in patients with diffuse pulmonary infiltrates and acute respiratory failure. Am Rev Respir Dis 1988; 137:90.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Walker WA, Cole FH Jr, Khandekar A, et al. Does open lung biopsy affect treatment in patients with diffuse pulmonary infiltrates? J Thorac Cardiovasc Surg 1989; 97:534.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Canver CC, Mentzer RM Jr. The role of open lung biopsy in early and late survival of ventilator-dependent patients with diffuse idiopathic lung disease. J Cardiovasc Surg (Torino) 1994; 35:151.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Papazian L, Thomas P, Bregeon F, et al. Open-lung biopsy in patients with acute respiratory distress syndrome. Anesthesiology 1998; 88:935.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Flabouris A, Myburgh J. The utility of open lung biopsy in patients requiring mechanical ventilation. Chest 1999; 115:811.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chuang ML, Lin IF, Tsai YH, et al. The utility of open lung biopsy in patients with diffuse pulmonary infiltrates as related to respiratory distress, its impact on decision making by urgent intervention, and the diagnostic accuracy based on the biopsy location. J Intensive Care Med 2003; 18:21.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zihlif M, Khanchandani G, Ahmed HP, Soubani AO. Surgical lung biopsy in patients with hematological malignancy or hematopoietic stem cell transplantation and unexplained pulmonary infiltrates: improved outcome with specific diagnosis. Am J Hematol 2005; 78:94.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Canzian M, Soeiro Ade M, Taga MF, et al. Correlation between surgical lung biopsy and autopsy findings and clinical data in patients with diffuse pulmonary infiltrates and acute respiratory failure. Clinics (Sao Paulo) 2006; 61:425.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barbas CS, Capelozzi VL, Hoelz C, et al. Impact of open lung biopsy on refractory acute respiratory failure. J Bras Pneumol 2006; 32:418.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kao KC, Tsai YH, Wu YK, et al. Open lung biopsy in early-stage acute respiratory distress syndrome. Crit Care 2006; 10:R106.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Papazian L, Doddoli C, Chetaille B, et al. A contributive result of open-lung biopsy improves survival in acute respiratory distress syndrome patients. Crit Care Med 2007; 35:755.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baumann HJ, Kluge S, Balke L, et al. Yield and safety of bedside open lung biopsy in mechanically ventilated patients with acute lung injury or acute respiratory distress syndrome. Surgery 2008; 143:426.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lin CY, Kao KC, Tian YC, et al. The RIFLE score increases the accuracy of outcome prediction in patients with acute respiratory distress syndrome undergoing open lung biopsy. Respiration 2009; 77:398.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chang CH, Kao KC, Hu HC, et al. The utility of surgical lung biopsy in cancer patients with acute respiratory distress syndrome. J Cardiothorac Surg 2013; 8:128.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Springmeyer SC, Hackman RC, Holle R, et al. Use of bronchoalveolar lavage to diagnose acute diffuse pneumonia in the immunocompromised host. J Infect Dis 1986; 154:604.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gaussorgues P, Piperno D, Bachmann P, et al. Comparison of nonbronchoscopic bronchoalveolar lavage to open lung biopsy for the bacteriologic diagnosis of pulmonary infections in mechanically ventilated patients. Intensive Care Med 1989; 15:94.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Churg A, Wright JL, Tazelaar HD. Acute exacerbations of fibrotic interstitial lung disease. Histopathology 2011; 58:525.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Churg A, Müller NL, Silva CI, Wright JL. Acute exacerbation (acute lung injury of unknown cause) in UIP and other forms of fibrotic interstitial pneumonias. Am J Surg Pathol 2007; 31:277.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Utz JP, Ryu JH, Douglas WW, et al. High short-term mortality following lung biopsy for usual interstitial pneumonia. Eur Respir J 2001; 17:175.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parambil JG, Myers JL, Ryu JH. Histopathologic features and outcome of patients with acute exacerbation of idiopathic pulmonary fibrosis undergoing surgical lung biopsy. Chest 2005; 128:3310.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Collard HR, Moore BB, Flaherty KR, et al. Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2007; 176:636.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ryerson CJ, Collard HR. Acute exacerbations complicating interstitial lung disease. Curr Opin Pulm Med 2014; 20:436.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mallick S. Outcome of patients with idiopathic pulmonary fibrosis (IPF) ventilated in intensive care unit. Respir Med 2008; 102:1355.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Blivet S, Philit F, Sab JM, et al. Outcome of patients with idiopathic pulmonary fibrosis admitted to the ICU for respiratory failure. Chest 2001; 120:209.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fumeaux T, Rothmeier C, Jolliet P. Outcome of mechanical ventilation for acute respiratory failure in patients with pulmonary fibrosis. Intensive Care Med 2001; 27:1868.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lynch DA, Sverzellati N, Travis WD, et al. Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper. Lancet Respir Med 2018; 6:138.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Raghu G, Remy-Jardin M, Myers JL, et al. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med 2018; 198:e44.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Raghu G, Remy-Jardin M, Richeldi L, et al. Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med 2022; 205:e18.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Babiak A, Hetzel J, Krishna G, et al. Transbronchial cryobiopsy: a new tool for lung biopsies. Respiration 2009; 78:203.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ravaglia C, Bonifazi M, Wells AU, et al. Safety and Diagnostic Yield of Transbronchial Lung Cryobiopsy in Diffuse Parenchymal Lung Diseases: A Comparative Study versus Video-Assisted Thoracoscopic Lung Biopsy and a Systematic Review of the Literature. Respiration 2016; 91:215.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Johannson KA, Marcoux VS, Ronksley PE, Ryerson CJ. Diagnostic Yield and Complications of Transbronchial Lung Cryobiopsy for Interstitial Lung Disease. A Systematic Review and Metaanalysis. Ann Am Thorac Soc 2016; 13:1828.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Raparia K, Aisner DL, Allen TC, et al. Transbronchial Lung Cryobiopsy for Interstitial Lung Disease Diagnosis: A Perspective From Members of the Pulmonary Pathology Society. Arch Pathol Lab Med 2016.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hetzel J, Maldonado F, Ravaglia C, et al. Transbronchial Cryobiopsies for the Diagnosis of Diffuse Parenchymal Lung Diseases: Expert Statement from the Cryobiopsy Working Group on Safety and Utility and a Call for Standardization of the Procedure. Respiration 2018; 95:188.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hetzel J, Wells AU, Costabel U, et al. Transbronchial cryobiopsy increases diagnostic confidence in interstitial lung disease: a prospective multicentre trial. Eur Respir J 2020; 56.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maldonado F, Danoff SK, Wells AU, et al. Transbronchial Cryobiopsy for the Diagnosis of Interstitial Lung Diseases: CHEST Guideline and Expert Panel Report. Chest 2020; 157:1030.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fruchter O, Fridel L, El Raouf BA, et al. Histological diagnosis of interstitial lung diseases by cryo-transbronchial biopsy. Respirology 2014; 19:683.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Casoni GL, Tomassetti S, Cavazza A, et al. Transbronchial lung cryobiopsy in the diagnosis of fibrotic interstitial lung diseases. PLoS One 2014; 9:e86716.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ravaglia C, Wells AU, Tomassetti S, et al. Diagnostic yield and risk/benefit analysis of trans-bronchial lung cryobiopsy in diffuse parenchymal lung diseases: a large cohort of 699 patients. BMC Pulm Med 2019; 19:16.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Poletti V, Ravaglia C, Gurioli C, et al. Invasive diagnostic techniques in idiopathic interstitial pneumonias. Respirology 2016; 21:44.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Poletti V, Hetzel J. Transbronchial Cryobiopsy in Diffuse Parenchymal Lung Disease: Need for Procedural Standardization. Respiration 2015; 90:275.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Korevaar DA, Colella S, Fally M, et al. European Respiratory Society guidelines on transbronchial lung cryobiopsy in the diagnosis of interstitial lung diseases. Eur Respir J 2022; 60.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kheir F, Uribe Becerra JP, Bissell B, et al. Transbronchial Lung Cryobiopsy in Patients with Interstitial Lung Disease: A Systematic Review. Ann Am Thorac Soc 2022; 19:1193.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rodrigues I, Estêvão Gomes R, Coutinho LM, et al. Diagnostic yield and safety of transbronchial lung cryobiopsy and surgical lung biopsy in interstitial lung diseases: a systematic review and meta-analysis. Eur Respir Rev 2022; 31.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Freund O, Wand O, Schneer S, et al. Transbronchial Cryobiopsy Is Superior to Forceps Biopsy for Diagnosing both Fibrotic and Non-Fibrotic Interstitial Lung Diseases. Respiration 2023; 102:852.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Troy LK, Grainge C, Corte TJ, et al. Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): a prospective, comparative study. Lancet Respir Med 2020; 8:171.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bondue B, Schlossmacher P, Allou N, et al. Trans-bronchial lung cryobiopsy in patients at high-risk of complications. BMC Pulm Med 2021; 21:135.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Romagnoli M, Colby TV, Berthet JP, et al. Poor Concordance between Sequential Transbronchial Lung Cryobiopsy and Surgical Lung Biopsy in the Diagnosis of Diffuse Interstitial Lung Diseases. Am J Respir Crit Care Med 2019; 199:1249.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tomassetti S, Ravaglia C, Wells AU, et al. Prognostic value of transbronchial lung cryobiopsy for the multidisciplinary diagnosis of idiopathic pulmonary fibrosis: a retrospective validation study. Lancet Respir Med 2020; 8:786.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Davidsen JR, Skov IR, Louw IG, Laursen CB. Implementation of transbronchial lung cryobiopsy in a tertiary referral center for interstitial lung diseases: a cohort study on diagnostic yield, complications, and learning curves. BMC Pulm Med 2021; 21:67.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hagmeyer L, Theegarten D, Wohlschläger J, et al. The role of transbronchial cryobiopsy and surgical lung biopsy in the diagnostic algorithm of interstitial lung disease. Clin Respir J 2016; 10:589.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kropski JA, Pritchett JM, Mason WR, et al. Bronchoscopic cryobiopsy for the diagnosis of diffuse parenchymal lung disease. PLoS One 2013; 8:e78674.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pajares V, Puzo C, Castillo D, et al. Diagnostic yield of transbronchial cryobiopsy in interstitial lung disease: a randomized trial. Respirology 2014; 19:900.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hernández-González F, Lucena CM, Ramírez J, et al. Cryobiopsy in the diagnosis of diffuse interstitial lung disease: yield and cost-effectiveness analysis. Arch Bronconeumol 2015; 51:261.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hagmeyer L, Theegarten D, Treml M, et al. Validation of transbronchial cryobiopsy in interstitial lung disease - interim analysis of a prospective trial and critical review of the literature. Sarcoidosis Vasc Diffuse Lung Dis 2016; 33:2.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hagmeyer L, Theegarten D, Wohlschläger J, et al. Transbronchial cryobiopsy in fibrosing interstitial lung disease: modifications of the procedure lead to risk reduction. Thorax 2019; 74:711.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tomic R, Cortes-Puentes GA, Murugan P, et al. Acute Exacerbation of Interstitial Lung Disease After Cryobiopsy. J Bronchology Interv Pulmonol 2017; 24:319.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ribeiro Neto ML, Arrossi AV, Yadav R, et al. Prospective cohort of cryobiopsy in interstitial lung diseases: a single center experience. BMC Pulm Med 2022; 22:215.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee YC, Wu CT, Hsu HH, et al. Surgical lung biopsy for diffuse pulmonary disease: experience of 196 patients. J Thorac Cardiovasc Surg 2005; 129:984.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lettieri CJ, Veerappan GR, Helman DL, et al. Outcomes and safety of surgical lung biopsy for interstitial lung disease. Chest 2005; 127:1600.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Flaherty KR, King TE Jr, Raghu G, et al. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am J Respir Crit Care Med 2004; 170:904.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morell F, Reyes L, Doménech G, et al. [Diagnoses and diagnostic procedures in 500 consecutive patients with clinical suspicion of interstitial lung disease]. Arch Bronconeumol 2008; 44:185.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Qureshi RA, Ahmed TA, Grayson AD, et al. Does lung biopsy help patients with interstitial lung disease? Eur J Cardiothorac Surg 2002; 21:621.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ravini M, Ferraro G, Barbieri B, et al. Changing strategies of lung biopsies in diffuse lung diseases: the impact of video-assisted thoracoscopy. Eur Respir J 1998; 11:99.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zegdi R, Azorin J, Tremblay B, et al. Videothoracoscopic lung biopsy in diffuse infiltrative lung diseases: a 5-year surgical experience. Ann Thorac Surg 1998; 66:1170.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tiitto L, Heiskanen U, Bloigu R, et al. Thoracoscopic lung biopsy is a safe procedure in diagnosing usual interstitial pneumonia. Chest 2005; 128:2375.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miller JD, Urschel JD, Cox G, et al. A randomized, controlled trial comparing thoracoscopy and limited thoracotomy for lung biopsy in interstitial lung disease. Ann Thorac Surg 2000; 70:1647.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ayed AK, Raghunathan R. Thoracoscopy versus open lung biopsy in the diagnosis of interstitial lung disease: a randomised controlled trial. J R Coll Surg Edinb 2000; 45:159.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kondoh Y, Taniguchi H, Kitaichi M, et al. Acute exacerbation of interstitial pneumonia following surgical lung biopsy. Respir Med 2006; 100:1753.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Padley SP, Jordan SJ, Goldstraw P, et al. Asymmetric ARDS following pulmonary resection: CT findings initial observations. Radiology 2002; 223:468.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sato T, Teramukai S, Kondo H, et al. Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer. J Thorac Cardiovasc Surg 2014; 147:1604.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fernández-Pérez ER, Yilmaz M, Jenad H, et al. Ventilator settings and outcome of respiratory failure in chronic interstitial lung disease. Chest 2008; 133:1113.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Raghu G. Interstitial lung disease: a diagnostic approach. Are CT scan and lung biopsy indicated in every patient? Am J Respir Crit Care Med 1995; 151:909.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gaensler EA, Carrington CB. Open biopsy for chronic diffuse infiltrative lung disease: clinical, roentgenographic, and physiological correlations in 502 patients. Ann Thorac Surg 1980; 30:411.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Blanco M, Obeso GA, Durán JC, et al. Surgical lung biopsy for diffuse lung disease. Our experience in the last 15 years. Rev Port Pneumol 2013; 19:59.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Flint A, Martinez FJ, Young ML, et al. Influence of sample number and biopsy site on the histologic diagnosis of diffuse lung disease. Ann Thorac Surg 1995; 60:1605.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Katzenstein AL, Zisman DA, Litzky LA, et al. Usual interstitial pneumonia: histologic study of biopsy and explant specimens. Am J Surg Pathol 2002; 26:1567.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Flaherty KR, Travis WD, Colby TV, et al. Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med 2001; 164:1722.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Monaghan H, Wells AU, Colby TV, et al. Prognostic implications of histologic patterns in multiple surgical lung biopsies from patients with idiopathic interstitial pneumonias. Chest 2004; 125:522.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Trahan S, Hanak V, Ryu JH, Myers JL. Role of surgical lung biopsy in separating chronic hypersensitivity pneumonia from usual interstitial pneumonia/idiopathic pulmonary fibrosis: analysis of 31 biopsies from 15 patients. Chest 2008; 134:126.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miller RR, Nelems B, Müller NL, et al. Lingular and right middle lobe biopsy in the assessment of diffuse lung disease. Ann Thorac Surg 1987; 44:269.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Temes RT, Joste NE, Allen NL, et al. The lingula is an appropriate site for lung biopsy. Ann Thorac Surg 2000; 69:1016.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ayed AK. Video-assisted thoracoscopic lung biopsy in the diagnosis of diffuse interstitial lung disease. A prospective study. J Cardiovasc Surg (Torino) 2003; 44:115.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hutchinson JP, Fogarty AW, McKeever TM, Hubbard RB. In-Hospital Mortality after Surgical Lung Biopsy for Interstitial Lung Disease in the United States. 2000 to 2011. Am J Respir Crit Care Med 2016; 193:1161.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sigurdsson MI, Isaksson HJ, Gudmundsson G, Gudbjartsson T. Diagnostic surgical lung biopsies for suspected interstitial lung diseases: a retrospective study. Ann Thorac Surg 2009; 88:227.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Han Q, Luo Q, Xie JX, et al. Diagnostic yield and postoperative mortality associated with surgical lung biopsy for evaluation of interstitial lung diseases: A systematic review and meta-analysis. J Thorac Cardiovasc Surg 2015; 149:1394.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Raj R, Brown KK. Mortality Related to Surgical Lung Biopsy in Patients with Interstitial Lung Disease. The Devil Is in the Denominator. Am J Respir Crit Care Med 2016; 193:1082.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Blewett CJ, Bennett WF, Miller JD, Urschel JD. Open lung biopsy as an outpatient procedure. Ann Thorac Surg 2001; 71:1113.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ishie RT, Cardoso JJ, Silveira RJ, Stocco L. Video-assisted thoracoscopy for the diagnosis of diffuse parenchymal lung disease. J Bras Pneumol 2009; 35:234.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fibla JJ, Molins L, Blanco A, et al. Video-assisted thoracoscopic lung biopsy in the diagnosis of interstitial lung disease: a prospective, multi-center study in 224 patients. Arch Bronconeumol 2012; 48:81.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           LoCicero J 3rd. Does every patient with enigmatic lung disease deserve a lung biopsy? The continuing dilemma. Chest 1994; 106:706.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kreider ME, Hansen-Flaschen J, Ahmad NN, et al. Complications of video-assisted thoracoscopic lung biopsy in patients with interstitial lung disease. Ann Thorac Surg 2007; 83:1140.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kayatta MO, Ahmed S, Hammel JA, et al. Surgical biopsy of suspected interstitial lung disease is superior to radiographic diagnosis. Ann Thorac Surg 2013; 96:399.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Park JH, Kim DK, Kim DS, et al. Mortality and risk factors for surgical lung biopsy in patients with idiopathic interstitial pneumonia. Eur J Cardiothorac Surg 2007; 31:1115.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fibla JJ, Brunelli A, Allen MS, et al. Microbiology specimens obtained at the time of surgical lung biopsy for interstitial lung disease: clinical yield and cost analysis. Eur J Cardiothorac Surg 2012; 41:36.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Churg A. An inflation procedure for open lung biopsies. Am J Surg Pathol 1983; 7:69.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 4379 Version 30.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15031564" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Diagnostic invasive procedures in diffuse infiltrative lung diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15919344" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Role of thoracic surgeons in the diagnosis of idiopathic interstitial lung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12119229" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : The relationship between individual histologic features and disease progression in idiopathic pulmonary fibrosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29178216" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Diagnostic utility of surgical lung biopsies in elderly patients with indeterminate interstitial lung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18757459" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16899488" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Is bronchoscopic lung biopsy helpful in the management of patients with diffuse lung disease?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17516743" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Transbronchial biopsy interpretation in the patient with diffuse parenchymal lung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17516743" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Transbronchial biopsy interpretation in the patient with diffuse parenchymal lung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27287583" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : A Prospective Randomized Controlled Trial Comparing the Efficacy and Safety of Cup vs Alligator Forceps for Performing Transbronchial Lung Biopsy in Patients With Sarcoidosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27471113" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Surgical Lung Biopsy for Interstitial Lung Diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11665502" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Lung biopsy in diffuse parenchymal lung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23001801" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Cryptogenic organizing pneumonia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16685001" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Transbronchial biopsy in usual interstitial pneumonia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23107232" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Transbronchial biopsy is useful in predicting UIP pattern.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20518887" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Histopathologic findings of transbronchial biopsy in usual interstitial pneumonia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21471066" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16684996" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Transbronchial biopsy and usual interstitial pneumonia: a new paradigm?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26628758" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Transbronchial lung biopsy in patients with diffuse parenchymal lung disease without 'idiopathic pulmonary fibrosis pattern' on HRCT scan - Experience from a tertiary care center of North India.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9401359" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Transbronchial lung biopsy: an analysis of 530 cases with reference to the number of samples.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9554644" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Transbronchial lung biopsy: can specimen quality be predicted at the time of biopsy?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23168725" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : The effect of cup versus alligator forceps on the results of transbronchial lung biopsy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19213774" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Does CT scanning predict the likelihood of a positive transbronchial biopsy in sarcoidosis?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11469500" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Comparison of endobronchial and transbronchial biopsies with high-resolution CT (HRCIT) in the diagnosis of sarcoidosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7357943" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Transbronchoscopic lung biopsy in sarcoidosis. Optimal number and sites for diagnosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10543279" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Medical thoracoscopic lung biopsy in interstitial lung disease: a prospective study of biopsy quality.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1882112" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Endobronchial biopsy positive sarcoidosis: relation to bronchoalveolar lavage and course of disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19674882" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : The role of EBUS-TBNA for the diagnosis of sarcoidosis--comparisons with other bronchoscopic diagnostic modalities.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18403656" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Clinically significant interstitial lung disease in limited scleroderma: histopathology, clinical features, and survival.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12070056" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23065360" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24576924" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Predictors of mortality and progression in scleroderma-associated interstitial lung disease: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22560113" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Rheumatoid lung disease: prognostic analysis of 54 biopsy-proven cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17218621" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23457378" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24126367" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Rheumatoid arthritis-associated interstitial lung disease: radiologic identification of usual interstitial pneumonia pattern.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20884744" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Lung diseases directly associated with rheumatoid arthritis and their relationship to outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14718441" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : The role of open-lung biopsy in ARDS.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3337474" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Open lung biopsy in patients with diffuse pulmonary infiltrates and acute respiratory failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2927158" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Does open lung biopsy affect treatment in patients with diffuse pulmonary infiltrates?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8195276" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : The role of open lung biopsy in early and late survival of ventilator-dependent patients with diffuse idiopathic lung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9579502" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Open-lung biopsy in patients with acute respiratory distress syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10084496" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : The utility of open lung biopsy in patients requiring mechanical ventilation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15189664" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : The utility of open lung biopsy in patients with diffuse pulmonary infiltrates as related to respiratory distress, its impact on decision making by urgent intervention, and the diagnostic accuracy based on the biopsy location.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15682425" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Surgical lung biopsy in patients with hematological malignancy or hematopoietic stem cell transplantation and unexplained pulmonary infiltrates: improved outcome with specific diagnosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17072440" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Correlation between surgical lung biopsy and autopsy findings and clinical data in patients with diffuse pulmonary infiltrates and acute respiratory failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17268745" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Impact of open lung biopsy on refractory acute respiratory failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16859510" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Open lung biopsy in early-stage acute respiratory distress syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17255856" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : A contributive result of open-lung biopsy improves survival in acute respiratory distress syndrome patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18291264" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Yield and safety of bedside open lung biopsy in mechanically ventilated patients with acute lung injury or acute respiratory distress syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19077383" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : The RIFLE score increases the accuracy of outcome prediction in patients with acute respiratory distress syndrome undergoing open lung biopsy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23680446" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : The utility of surgical lung biopsy in cancer patients with acute respiratory distress syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3018093" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Use of bronchoalveolar lavage to diagnose acute diffuse pneumonia in the immunocompromised host.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2715513" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Comparison of nonbronchoscopic bronchoalveolar lavage to open lung biopsy for the bacteriologic diagnosis of pulmonary infections in mechanically ventilated patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20854464" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Acute exacerbations of fibrotic interstitial lung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17255773" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Acute exacerbation (acute lung injury of unknown cause) in UIP and other forms of fibrotic interstitial pneumonias.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11334116" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : High short-term mortality following lung biopsy for usual interstitial pneumonia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16304277" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Histopathologic features and outcome of patients with acute exacerbation of idiopathic pulmonary fibrosis undergoing surgical lung biopsy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17585107" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Acute exacerbations of idiopathic pulmonary fibrosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25032813" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Acute exacerbations complicating interstitial lung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18635345" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Outcome of patients with idiopathic pulmonary fibrosis (IPF) ventilated in intensive care unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11451840" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Outcome of patients with idiopathic pulmonary fibrosis admitted to the ICU for respiratory failure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11797021" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Outcome of mechanical ventilation for acute respiratory failure in patients with pulmonary fibrosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29154106" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30168753" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35486072" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19246874" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Transbronchial cryobiopsy: a new tool for lung biopsies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26926876" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Safety and Diagnostic Yield of Transbronchial Lung Cryobiopsy in Diffuse Parenchymal Lung Diseases: A Comparative Study versus Video-Assisted Thoracoscopic Lung Biopsy and a Systematic Review of the Literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27466899" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Diagnostic Yield and Complications of Transbronchial Lung Cryobiopsy for Interstitial Lung Disease. A Systematic Review and Metaanalysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27441784" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Transbronchial Lung Cryobiopsy for Interstitial Lung Disease Diagnosis: A Perspective From Members of the Pulmonary Pathology Society.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29316560" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Transbronchial Cryobiopsies for the Diagnosis of Diffuse Parenchymal Lung Diseases: Expert Statement from the Cryobiopsy Working Group on Safety and Utility and a Call for Standardization of the Procedure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32817003" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Transbronchial cryobiopsy increases diagnostic confidence in interstitial lung disease: a prospective multicentre trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31783014" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Transbronchial Cryobiopsy for the Diagnosis of Interstitial Lung Diseases: CHEST Guideline and Expert Panel Report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24750376" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Histological diagnosis of interstitial lung diseases by cryo-transbronchial biopsy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24586252" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Transbronchial lung cryobiopsy in the diagnosis of fibrotic interstitial lung diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30651103" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Diagnostic yield and risk/benefit analysis of trans-bronchial lung cryobiopsy in diffuse parenchymal lung diseases: a large cohort of 699 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26682637" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Invasive diagnostic techniques in idiopathic interstitial pneumonias.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26384323" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Transbronchial Cryobiopsy in Diffuse Parenchymal Lung Disease: Need for Procedural Standardization.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35710261" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : European Respiratory Society guidelines on transbronchial lung cryobiopsy in the diagnosis of interstitial lung diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35499855" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Transbronchial Lung Cryobiopsy in Patients with Interstitial Lung Disease: A Systematic Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36198419" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Diagnostic yield and safety of transbronchial lung cryobiopsy and surgical lung biopsy in interstitial lung diseases: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37634496" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Transbronchial Cryobiopsy Is Superior to Forceps Biopsy for Diagnosing both Fibrotic and Non-Fibrotic Interstitial Lung Diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31578168" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): a prospective, comparative study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33902504" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Trans-bronchial lung cryobiopsy in patients at high-risk of complications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30864813" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Poor Concordance between Sequential Transbronchial Lung Cryobiopsy and Surgical Lung Biopsy in the Diagnosis of Diffuse Interstitial Lung Diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32763205" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Prognostic value of transbronchial lung cryobiopsy for the multidisciplinary diagnosis of idiopathic pulmonary fibrosis: a retrospective validation study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33632180" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Implementation of transbronchial lung cryobiopsy in a tertiary referral center for interstitial lung diseases: a cohort study on diagnostic yield, complications, and learning curves.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25620578" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : The role of transbronchial cryobiopsy and surgical lung biopsy in the diagnostic algorithm of interstitial lung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24265706" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Bronchoscopic cryobiopsy for the diagnosis of diffuse parenchymal lung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24890124" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Diagnostic yield of transbronchial cryobiopsy in interstitial lung disease: a randomized trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25454902" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Cryobiopsy in the diagnosis of diffuse interstitial lung disease: yield and cost-effectiveness analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27055830" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Validation of transbronchial cryobiopsy in interstitial lung disease - interim analysis of a prospective trial and critical review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30852561" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Transbronchial cryobiopsy in fibrosing interstitial lung disease: modifications of the procedure lead to risk reduction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28525523" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Acute Exacerbation of Interstitial Lung Disease After Cryobiopsy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35655191" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Prospective cohort of cryobiopsy in interstitial lung diseases: a single center experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15867770" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Surgical lung biopsy for diffuse pulmonary disease: experience of 196 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15888834" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Outcomes and safety of surgical lung biopsy for interstitial lung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15256390" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18423179" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : [Diagnoses and diagnostic procedures in 500 consecutive patients with clinical suspicion of interstitial lung disease].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11932157" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Does lung biopsy help patients with interstitial lung disease?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9543277" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Changing strategies of lung biopsies in diffuse lung diseases: the impact of video-assisted thoracoscopy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9800801" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Videothoracoscopic lung biopsy in diffuse infiltrative lung diseases: a 5-year surgical experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16236897" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Thoracoscopic lung biopsy is a safe procedure in diagnosing usual interstitial pneumonia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11093503" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : A randomized, controlled trial comparing thoracoscopy and limited thoracotomy for lung biopsy in interstitial lung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10881481" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Thoracoscopy versus open lung biopsy in the diagnosis of interstitial lung disease: a randomised controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16584880" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Acute exacerbation of interstitial pneumonia following surgical lung biopsy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11997554" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Asymmetric ARDS following pulmonary resection: CT findings initial observations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24267779" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17989156" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : Ventilator settings and outcome of respiratory failure in chronic interstitial lung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7881691" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : Interstitial lung disease: a diagnostic approach. Are CT scan and lung biopsy indicated in every patient?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7436611" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : Open biopsy for chronic diffuse infiltrative lung disease: clinical, roentgenographic, and physiological correlations in 502 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23395290" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : Surgical lung biopsy for diffuse lung disease. Our experience in the last 15 years.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8787450" id="rid111" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          112 : Influence of sample number and biopsy site on the histologic diagnosis of diffuse lung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12459623" id="rid112" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          113 : Usual interstitial pneumonia: histologic study of biopsy and explant specimens.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11719316" id="rid113" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          114 : Histopathologic variability in usual and nonspecific interstitial pneumonias.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14769733" id="rid114" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          115 : Prognostic implications of histologic patterns in multiple surgical lung biopsies from patients with idiopathic interstitial pneumonias.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18339775" id="rid115" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          116 : Role of surgical lung biopsy in separating chronic hypersensitivity pneumonia from usual interstitial pneumonia/idiopathic pulmonary fibrosis: analysis of 31 biopsies from 15 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3632113" id="rid116" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          117 : Lingular and right middle lobe biopsy in the assessment of diffuse lung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10800786" id="rid117" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          118 : The lingula is an appropriate site for lung biopsy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12627082" id="rid118" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          119 : Video-assisted thoracoscopic lung biopsy in the diagnosis of diffuse interstitial lung disease. A prospective study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26646481" id="rid119" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          120 : In-Hospital Mortality after Surgical Lung Biopsy for Interstitial Lung Disease in the United States. 2000 to 2011.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19559230" id="rid120" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          121 : Diagnostic surgical lung biopsies for suspected interstitial lung diseases: a retrospective study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25648484" id="rid121" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          122 : Diagnostic yield and postoperative mortality associated with surgical lung biopsy for evaluation of interstitial lung diseases: A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27174478" id="rid122" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          123 : Mortality Related to Surgical Lung Biopsy in Patients with Interstitial Lung Disease. The Devil Is in the Denominator.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11308145" id="rid123" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          124 : Open lung biopsy as an outpatient procedure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19390721" id="rid124" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          125 : Video-assisted thoracoscopy for the diagnosis of diffuse parenchymal lung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22244947" id="rid125" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          126 : Video-assisted thoracoscopic lung biopsy in the diagnosis of interstitial lung disease: a prospective, multi-center study in 224 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8082344" id="rid126" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          127 : Does every patient with enigmatic lung disease deserve a lung biopsy? The continuing dilemma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17307476" id="rid127" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          128 : Complications of video-assisted thoracoscopic lung biopsy in patients with interstitial lung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23791163" id="rid128" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          129 : Surgical biopsy of suspected interstitial lung disease is superior to radiographic diagnosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17418586" id="rid129" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          130 : Mortality and risk factors for surgical lung biopsy in patients with idiopathic interstitial pneumonia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21601471" id="rid130" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          131 : Microbiology specimens obtained at the time of surgical lung biopsy for interstitial lung disease: clinical yield and cost analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6338751" id="rid131" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          132 : An inflation procedure for open lung biopsies.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
